NFKB1 and psoriasis: Moreover, several KCs-associated mutations activating the NF-κB pathway were identified in psoriasis patients, including gain-of-function mutations in the CARD14 gene that encodes an activator of NF-κB signaling or loss-of-function in the TNFAIP3 gene that encodes an inhibitor of NF-κB pathway [265].